Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression difference between stem cell Krt6a+ and differentiated cell WAP+ in mammary precancerous early lesions

ABSTRACT: Expression difference between stem cell Krt6a+ and differentiated cell WAP+ in mammary precancerous early lesions

PROVIDER: PRJNA420757 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6338450.fastq.gz	Fastqsanger.gz
	SRR6338451.fastq.gz	Fastqsanger.gz
	SRR6338447.fastq.gz	Fastqsanger.gz
	SRR6338448.fastq.gz	Fastqsanger.gz
	SRR6338449.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Expression difference between stem cell Krt6a+ and differentiated cell WAP+ in mammary precancerous early lesions

Project description:The stem cell hierarchy of normal tissues has been studied extensively for cancer origin, but the stem cell hierarchy of precancerous lesions and its contribution to tumorigenesis remain elusive. Here, we report that in MMTV-Wnt1 transgenic mice, mammary precancerous lesions harbor both keratin 6a+ precancerous stem cells (pcSC) and more differentiated whey acidic protein (WAP)+ cells. The goal of these data was to understand expression differences between different subsets of cells in mammary precancerous early lesions. There are two cell lines Krt6a+ cells (stem cells) and WAP+ cell (more differentiated cells) from hyperplastic mammary glands in MMTV-Wnt1 mice.

2025-03-04 | GSE107608 | GEO

Microscopic Characteristics of Wind-damp Syndrome in Gastric Precancerous Lesions

Project description:Base on the classification of damp syndrome, we classified gastric precancerous lesions patients into distinct subtypes. In this cross-sectional investigation, we aim figure out the clinical feature difference between different subtypes. Furthermore, we conduct multi-omics analyses on blood samples to explore the microscopic biological feature of WD syndrome of gastric precancerous lesions. Our study aimed to illuminate the macroscopic and microscopic characteristics of WD syndrome in gastric precancerous lesions, which will provide a evidence for therapeutic strategies aimed at addressing WD syndrome of gastric precancerous lesions.

2025-04-03 | PXD062653 |

Biomarkers of colorectal precancerous lesions

Project description:Biomarkers of colorectal precancerous lesions

| PRJNA970834 | ENA

Validation of differentially methylated DNA regions in colorectal precancerous lesions.

Project description:In this study, we validated 992 previously identified differentially methylated regions (DMRs) in colorectal precancerous lesions compared to adjacent normal mucosa in a new series of 59 prospectively collected lesions and matched normal tissue using targeted bisulfite sequencing. Strong differences in methylation level were observed across the full set of validated DMRs. Based on the mean methylation levels of a panel of 30 selected DMRs tumors could be accurately classified. We thus provide a large list of validated DNA markers to be exploited in the development of noninvasive, colorectal tumor screening assays.

2023-03-30 | E-MTAB-12612 | biostudies-arrayexpress

Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions

Project description:Studying precancerous lesions is essential for improving early detection and prevention, particularly in aggressive cancers such as ovarian carcinoma. Here, we conducted integrated and spatial analyses of transcriptomes, aneuploidy, and clinicopathological features in 166 ovarian precancerous lesions. Four pre-cancerous transcriptomic subtypes were identified: proliferative, immunoreactive, dormant, and mixed. These subtypes varied in their frequency of germline-BRCA1/2 mutations, aneuploidy, CCNE1/MYC amplification, proliferative activity, immune-regulatory gene expression, and histological features. Notably, the immunoreactive subtype upregulated immune-regulatory genes, exhibited chronic inflammation, and was enriched in cases with germline-BRCA1/2 mutations, deletions of chromosomes 17 (harboring TP53 and BRCA1) and 13 (harboring BRCA2), leading to a double “two-hit” involving TP53 and BRCA1/2. Tumor invasion was associated with the activation of interferon response pathways, epithelial-mesenchymal transition, and extracellular matrix remodeling. In summary, these results elucidate the earliest molecular landscape of ovarian precancerous lesions, serving as the foundation for future risk stratification to identify aggressive pre-cancerous lesions.

2025-12-06 | GSE298031 | GEO

Label-based comparative proteomics to understand progression of precancerous lesions to oral squamous cell carcinoma

Project description:Oral squamous cell carcinomas typically arise from precancerous lesions such as leukoplakia and erythroplakia. These lesions exhibit a range of histological changes from hyperplasia to dysplasia and carcinoma in situ, during their transformation to malignancy. The molecular mechanisms driving this multistage transition remain incompletely understood. To bridge this knowledge gap, our current study utilizes label based comparative proteomics to compare protein expression profiles across different histopathological grades of leukoplakia, erythroplakia, and OSCC samples, aiming to elucidate the molecular changes underlying lesion evolution.

2025-05-07 | PXD054190 | Pride

Label-based comparative proteomics to understand progression of precancerous lesions to oral squamous cell carcinoma

2025-10-06 | MSV000099404 | MassIVE

T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions

Project description:T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions

| PRJNA1075091 | ENA

Loss of NADPH-producing enzymes accelerates pancreatic precancerous lesions

Project description:Loss of NADPH-producing enzymes accelerates pancreatic precancerous lesions

| PRJNA1381359 | ENA

Loss of NADPH-producing enzymes accelerates pancreatic precancerous lesions

Project description:Acinar-to-ductal metaplasia (ADM) is a reversible cell state that facilitates pancreas repair following injury. Oncogenic KRAS mutations can progress ADM to pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma. Metabolism is extensively reprogrammed in cancer, but the metabolic alterations in precancerous lesions are understudied. Using RNA-sequencing and targeted metabolomics from isolated acinar cells we identified global changes in central carbon metabolism genes and metabolites during ADM formation.

2025-12-15 | GSE313699 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data